CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 166 filers reported holding CARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $234,659 | +45113.7% | 47,792 | -1.1% | 0.00% | -50.0% |
| Q4 2022 | $519 | -99.9% | 48,306 | +17.5% | 0.00% | 0.0% |
| Q3 2022 | $385,000 | +9.4% | 41,119 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $352,000 | -19.8% | 38,594 | +6.9% | 0.00% | 0.0% |
| Q1 2022 | $439,000 | +12.9% | 36,096 | +13.1% | 0.00% | 0.0% |
| Q4 2021 | $389,000 | -21.1% | 31,920 | +0.1% | 0.00% | -33.3% |
| Q3 2021 | $493,000 | +4.7% | 31,902 | -3.4% | 0.01% | +20.0% |
| Q2 2021 | $471,000 | – | 33,033 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |